Cargando...
Targeting the RTK-PI3K-mTOR Axis in Malignant Glioma: Overcoming Resistance
Gliomas represent the most common primary brain tumor and among the most aggressive of cancers. Patients with glioma typically relapse within a year of initial diagnosis. Recurrent glioma is associated with acquired therapeutic resistance. Although neurosurgical resection, radiation and chemotherapy...
Guardado en:
Autores principales: | , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012004/ https://ncbi.nlm.nih.gov/pubmed/20535652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/82_2010_67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|